Free Trial

electroCore (ECOR) Competitors

electroCore logo
$6.02 +0.04 (+0.67%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$6.08 +0.06 (+1.00%)
As of 04/17/2025 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ECOR vs. LNSR, BWAY, CATX, LAKE, PROF, ZJYL, SKIN, SGHT, KRMD, and LUCD

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include LENSAR (LNSR), BrainsWay (BWAY), Perspective Therapeutics (CATX), Lakeland Industries (LAKE), Profound Medical (PROF), Jin Medical International (ZJYL), Beauty Health (SKIN), Sight Sciences (SGHT), KORU Medical Systems (KRMD), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry.

electroCore vs.

LENSAR (NASDAQ:LNSR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability.

electroCore received 161 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 37.50% of users gave LENSAR an outperform vote.

CompanyUnderperformOutperform
LENSAROutperform Votes
6
37.50%
Underperform Votes
10
62.50%
electroCoreOutperform Votes
167
62.55%
Underperform Votes
100
37.45%

LENSAR currently has a consensus target price of $15.00, suggesting a potential upside of 7.84%. electroCore has a consensus target price of $25.50, suggesting a potential upside of 323.59%. Given electroCore's stronger consensus rating and higher possible upside, analysts plainly believe electroCore is more favorable than LENSAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

LENSAR has higher revenue and earnings than electroCore. LENSAR is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$53.49M3.07-$14.38M-$2.72-5.11
electroCore$25.18M1.72-$18.83M-$1.62-3.72

LENSAR has a net margin of -34.03% compared to electroCore's net margin of -54.40%. LENSAR's return on equity of -49.02% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR-34.03% -49.02% -21.12%
electroCore -54.40%-154.45%-69.16%

LENSAR has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 38.5% of LENSAR shares are owned by company insiders. Comparatively, 19.7% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, electroCore had 3 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for electroCore and 1 mentions for LENSAR. LENSAR's average media sentiment score of 1.00 beat electroCore's score of 0.48 indicating that LENSAR is being referred to more favorably in the media.

Company Overall Sentiment
LENSAR Positive
electroCore Neutral

Summary

LENSAR and electroCore tied by winning 9 of the 18 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$43.30M$3.10B$5.30B$7.34B
Dividend YieldN/A1.79%5.12%4.30%
P/E Ratio-3.2914.8721.8617.80
Price / Sales1.7243.57380.5497.74
Price / CashN/A44.0938.2634.64
Price / Book4.853.336.453.98
Net Income-$18.83M$94.03M$3.22B$247.81M
7 Day Performance8.08%0.09%2.85%1.80%
1 Month Performance-28.16%-7.98%-8.67%-6.81%
1 Year Performance6.74%-20.04%11.46%1.31%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
3.211 of 5 stars
$6.02
+0.7%
$25.50
+323.6%
+6.7%$43.30M$25.18M-3.2950News Coverage
Gap Down
LNSR
LENSAR
0.9722 of 5 stars
$13.68
+1.4%
$15.00
+9.6%
+343.0%$161.27M$53.49M-9.37110Short Interest ↓
BWAY
BrainsWay
3.6416 of 5 stars
$8.32
-1.7%
$13.17
+58.3%
+72.0%$156.99M$41.02M83.21120Short Interest ↓
Positive News
Gap Down
CATX
Perspective Therapeutics
3.1892 of 5 stars
$2.05
+5.1%
$12.75
+522.0%
N/A$151.81M$1.43M0.0070Gap Up
LAKE
Lakeland Industries
4.8795 of 5 stars
$15.95
-0.5%
$28.25
+77.1%
-5.1%$151.51M$151.82M-177.221,800Analyst Forecast
PROF
Profound Medical
1.9942 of 5 stars
$4.76
+1.5%
$14.25
+199.4%
-39.0%$142.99M$10.68M-3.55150Gap Up
ZJYL
Jin Medical International
N/A$0.87
+18.7%
N/A-76.4%$135.87M$23.50M0.00245News Coverage
Positive News
Gap Up
SKIN
Beauty Health
1.7522 of 5 stars
$1.00
-4.8%
$2.50
+150.0%
-75.3%$125.25M$334.29M-2.381,030Gap Up
SGHT
Sight Sciences
3.2936 of 5 stars
$2.41
+1.3%
$3.83
+59.1%
-49.2%$123.71M$79.87M-2.36210Gap Up
KRMD
KORU Medical Systems
2.874 of 5 stars
$2.46
+7.0%
$4.70
+91.1%
+10.2%$113.05M$33.65M-9.8480
LUCD
Lucid Diagnostics
2.2221 of 5 stars
$1.19
+1.7%
$3.40
+185.7%
+51.3%$108.00M$4.35M-1.0470High Trading Volume

Related Companies and Tools


This page (NASDAQ:ECOR) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners